BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 34811504)

  • 1. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
    Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
    Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
    Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
    Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA technologies for the analysis of brain cancer.
    Mair R; Mouliere F
    Br J Cancer; 2022 Feb; 126(3):371-378. PubMed ID: 34811503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy.
    Trino S; Lamorte D; Caivano A; De Luca L; Sgambato A; Laurenzana I
    Leukemia; 2021 Mar; 35(3):661-678. PubMed ID: 33299143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
    Hu T; Wolfram J; Srivastava S
    Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
    Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy in Solid Malignancy.
    Scarlotta M; Simsek C; Kim AK
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid biopsy for liver diseases.
    Mann J; Reeves HL; Feldstein AE
    Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
    Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy: A Game Changer for Type 2 Diabetes.
    Gradisteanu Pircalabioru G; Musat M; Elian V; Iliescu C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering on the promise of early detection with liquid biopsies.
    Crosby D
    Br J Cancer; 2022 Feb; 126(3):313-315. PubMed ID: 35013576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of
    Cayrefourcq L; Alix-Panabières C
    Expert Rev Mol Diagn; 2020 Sep; 20(9):913-919. PubMed ID: 32856493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy approaches for pleural effusion in lung cancer patients.
    Baburaj G; Damerla RR; Udupa KS; Parida P; Munisamy M; Kolesar J; Rao M
    Mol Biol Rep; 2020 Oct; 47(10):8179-8187. PubMed ID: 33029702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and challenges of circulating biomarkers in neuroblastoma.
    Trigg RM; Shaw JA; Turner SD
    Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Liquid Biopsies in Pediatric Brain Tumors.
    Tang K; Gardner S; Snuderl M
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.